Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 

 

Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Jul 27, 2021

Jim Joyce is the Co-Founder, Chairman, and CEO of Sigyn Therapeutics, and we talk about removing inflammatory targets from the bloodstream with advanced blood purification technology.

Jim says, "The next transformative step in the recipe of blood purification is the advancement of devices that can address the sources of inflammation, which could be a viral or a bacterial source, in concert with the depletion of inflammatory cytokines and other modulators from the bloodstream."

"You need the ability to quickly modulate down these inflammatory cytokines, but you also need to be able to address the source of inflammation.  The source of inflammation continues to stimulate the immune response. The source of inflammation in COVID-19 is obviously the viral pathogen itself and related bacterial infections. We're very focused on looking at bacterial toxins as well."

#BloodPurification #COVID19 #Cytokinestorm #Cytokine #Sepsis  #Innovation #MedTwitter

SigynTherapeutics.com

Listen to the podcast here

Sigyn